Literature DB >> 1915487

Neonatal citrullinaemia with satisfactory mental development.

P Sanjurjo1, J Rodríguez-Soriano, A Vallo, A Arranz, V Rubio.   

Abstract

In an infant with neonatal citrullinaemia therapy was instituted on day 1 of life with a low-protein diet and oral supplements of arginine, alpha-keto-acids, essential amino acids and carnitine. The latter may have contributed to the excellent clinical outcome, as evidenced by normal growth and satisfactory psychomotor development at 3 years of age.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915487     DOI: 10.1007/bf01958766

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Serum carnitine during valproic acid therapy.

Authors:  M C Laub; I Paetzke-Brunner; G Jaeger
Journal:  Epilepsia       Date:  1986 Sep-Oct       Impact factor: 5.864

2.  Nitrogen metabolism in neonatal citrullinaemia.

Authors:  M Walser; M Batshaw; G Sherwood; B Robinson; S Brusilow
Journal:  Clin Sci Mol Med       Date:  1977-08

3.  Severe neonatal citrullinaemia.

Authors:  D M Danks; P Tippett; G Zentner
Journal:  Arch Dis Child       Date:  1974-07       Impact factor: 3.791

4.  First-trimester (chorion biopsy) diagnosis of citrullinaemia and methylmalonicaciduria.

Authors:  W J Kleijer; R Thoomes; H Galjaard; U Wendel; B Fowler
Journal:  Lancet       Date:  1984-12-08       Impact factor: 79.321

5.  L-carnitine for methylmalonicaciduria.

Authors:  D W Seccombe; F Snyder; H G Parsons
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

6.  Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.

Authors:  Y Ohtani; K Ohyanagi; S Yamamoto; I Matsuda
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

7.  Treatment of hyperammonemic coma caused by inborn errors of urea synthesis.

Authors:  M L Batshaw; S W Brusilow
Journal:  J Pediatr       Date:  1980-12       Impact factor: 4.406

8.  [Treatment of citrullinemia. Apropos of a case followed from birth. Importance of alpha-ketonic acids].

Authors:  D Tenenbaum; A M Petion; J Desgres; A Nivelon-Chevallier; P Gambert; J L Nivelon
Journal:  Arch Fr Pediatr       Date:  1987-12

9.  A case of carbamylphosphate synthetase-I deficiency associated with secondary carnitine deficiency--L-carnitine treatment of CPS-I deficiency.

Authors:  T Mori; A Tsuchiyama; K Nagai; M Nagao; K Oyanagi; S Tsugawa
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

10.  Effect of hyperammonemia on the levels of carnitine in mice.

Authors:  M Costell; M P Míguez; J E O'Connor; S Grisolía
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

View more
  1 in total

1.  Outcome of neonatal citrullinaemia.

Authors:  W Sperl
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.